The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
This win is on the back of a prestigious order from Reliance Life Sciences
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
Funds raised will be used to develop technology and foster healthcare partnerships
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Subscribe To Our Newsletter & Stay Updated
